Ryan Nelson
Editor-in-Chief, Medtech Insight, HBW Insight
Ryan has been covering the medical device and consumer health, wellness and beauty sectors since 2004, first as a reporter for Gray Sheet, where he covered beats including Capitol Hill, international and emerging technology, and then as managing editor of Rose Sheet. In his current role, he oversees and heads up strategy for their successor publications Medtech Insight and HBW Insight. He also manages and contributes regularly to HBW Insight’s Beauty channel with a focus on regulatory, policy and legal issues and has moderated related panels at industry events. Ryan has a growing role in developing podcasts, new features, “deep dive” article series, and infographics across teams and publications. Off the job, he enjoys spending time with his wife Katie, son Finn and daughter Maggie in Alexandria, VA, a DC suburb.
Latest From Ryan Nelson
Beauty Deserts, People With Disabilities, Hormonal Health: FIT Grads On Inclusivity Gaps
The Fashion Institute of Technology’s “Beauty Think Tank” provides findings from six months of consumer research to “help guide organizations through the evolving landscape of beauty and accessibility.”
Diversity Action Plans Should Be Brief And Waiver Requests Filed Early, US FDA Says
In what could amount to a de facto enforcement mechanism, the new draft guidance also “strongly encourages” sponsors to share details about their diversity action plan and enrollment goals with the public.
Hair-Care News: Connecticut Mandates Inclusive Hair Education; Fenty Hair; Virtue Labs, More
A Connecticut bill signed into law on 28 May requires barbers, hairdressers and cosmeticians to be educated and trained on textured hair. Niles + Chaz launches with four products designed for children with “mixed-textured hair,” while Rion Aesthetics says (plated) Hair Serum is the first and only product of its kind with platelet-derived exosomes. More hair-care news.
Click Therapeutics Anticipates Pharma Will Begin Developing Digital Drugs From Clinical Stage
Leading digital therapeutic maker’s CEO David Benshoof Klein and CMO Shaheen Lakhan discuss outlook on the DTx space, priorities going forward, and what makes Click a standout player in a changing game.
Click Therapeutics Anticipates Pharma Will Begin Developing Digital Drugs From Clinical Stage
Leading digital therapeutic maker’s CEO David Benshoof Klein and CMO Shaheen Lakhan discuss outlook on the DTx space, priorities going forward, and what makes Click a standout player in a changing game.
NOYZ Intends To Be Heard At Ulta Beauty This Summer
“In an industry that has long been rooted in hyper-filtered fantasy, we saw a massive white space in the fragrance market for a brand rooted in realism,” says NOYZ creator Shaun Neff. The brand is part of a newness infusion aimed at driving Ulta growth amid a broad-based prestige beauty slowdown.